Metabolic Testing Market Report 2026

Metabolic Testing Market Overview

• Metabolic Testing market size has reached to $0.64 billion in 2025 • Expected to grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Increase In Prevalence Of Chronic Diseases Is Driving The Market Growth • Market Trend: Technological Advancements In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Metabolic Testing Market?

Metabolic testing refers to a set of medical tests used to measure the body's metabolic rate, including how efficiently it converts food into energy and to assess various metabolic processes. These tests evaluate aspects and help determine a person's risk for obesity, diabetes, and cardiovascular diseases. The main types of metabolic testing are body composition analyzers, cardiopulmonary exercise testing (CPET) systems, electrocardiogram systems (ECG), metabolic carts, and other equipment types. Body composition analyzers refer to devices that measure the proportion of fat, muscle, and bone in the body to assess overall health and fitness. These are used for various routes of technologies, including VO₂ max analysis, RMR analysis, and body composition analysis. The various drug classes include critical care, lifestyle diseases, and other applications and are used by various end users such as hospitals and clinics, sports training centers, and other end users.

What Is The Metabolic Testing Market Growth Forecast?

The metabolic testing market size is expected to see strong growth in the next few years. It will grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in personalized wellness programs, increasing sports performance analytics, rising demand for remote health monitoring, expansion of wearable metabolic sensors, increasing integration of ai-based diagnostic tools. Major trends in the forecast period include adoption of personalized metabolic health programs, AI-based metabolic rate assessment and prediction, cloud-enabled data monitoring for metabolic testing, automation of metabolic testing equipment, real-time iot-based body analytics.

Global Metabolic Testing Market Segmentation

1) By Equipment Type: Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, Electrocardiogram Systems (ECG) Systems, Metabolic Carts, Other Equipment Types 2) By Technology: VO₂ Max Analysis, RMR Analysis, Body Composition Analysis 3) By Application: Critical Care, Lifestyle Diseases, Other Applications 4) By End User: Hospitals And Clinics, Sports Training Centers, Other End Users Subsegments: 1) By Body Composition Analyzers: Dual-Energy X-ray Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Air Displacement Plethysmography (ADP) 2) By Cardiopulmonary Exercise Testing (CPET) Systems: Treadmill Or Cycle Ergometer-based CPET, Oxygen Consumption Measurement Systems, Gas Exchange Measurement Systems 3) By Electrocardiogram (ECG) Systems: Resting ECG Systems, Stress ECG Systems, Holter Monitors 4) By Metabolic Carts: Indirect Calorimetry Metabolic Carts, Open-Circuit Spirometry Metabolic Carts 5) By Other Equipment Types: Continuous Glucose Monitoring Systems, Lactate Testing Devices, Blood Pressure Monitoring Devices

What Is The Driver Of The Metabolic Testing Market?

The increase in the prevalence of chronic diseases is expected to drive the metabolic testing market going forward. Chronic diseases refer to long-lasting conditions that typically persist for a year or more and require ongoing medical attention or limit activities of daily living. The prevalence of chronic diseases is due to unhealthy lifestyles, poor dietary habits, and an aging population. Metabolic testing plays a crucial role in managing chronic diseases by providing valuable insights into an individual's metabolic health, enabling early detection of conditions such as diabetes, cardiovascular diseases, and metabolic syndrome, which helps personalize treatment plans and improve overall disease management. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, 41 million deaths worldwide, accounting for 74% of all fatalities attributed to chronic diseases each year. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the increase in the prevalence of chronic diseases will drive the metabolic testing industry.

Key Players In The Global Metabolic Testing Market

Major companies operating in the metabolic testing market are Becton Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, Seca GmbH Co KG

Global Metabolic Testing Market Trends and Insights

Major companies operating in the metabolic testing market are focusing on developing innovative testing equipment, such as metabolic analyzers, to enhance real-time metabolic analysis and improve research accuracy. A metabolic analyzer is a medical device used to measure an individual's metabolic rate and assess various metabolic functions. It evaluates how efficiently the body utilizes oxygen and converts food into energy, providing insights into calorie expenditure, fuel utilization (carbohydrates vs. fats), and respiratory efficiency. For instance, in September 2024, PHC Corporation, a Japan-based company that provides healthcare solutions, launched LiCellMo, a live cell metabolic analyzer designed for real-time visualization of cellular metabolism in cell and gene therapy research. The LiCellMo live cell metabolic analyzer offers unique features such as real-time, continuous, and non-invasive monitoring of glucose and lactate concentrations in cell cultures, providing a comprehensive view of cellular metabolism without disrupting the experiment. It allows researchers to visualize metabolic changes in cell cultures, providing a more complete picture of cell activity.

What Are Latest Mergers And Acquisitions In The Metabolic Testing Market?

In September 2024, Oura, a Finland-based health technology company, acquired Veri. Through this acquisition, Oura aims to enhance its health-tracking capabilities by integrating metabolic health insights, particularly meal timing and blood sugar analysis, into the Oura app, providing users with a more holistic view of their overall health. Veri is a Finland-based developer of a blood sugar monitoring system that involves metabolic testing.

Regional Outlook

North America was the dominant region in the metabolic testing market in 2025. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Metabolic Testing Market?

The metabolic testing market consists of revenues earned by entities through services such as measuring resting metabolic rate (RMR), analyzing body composition, assessing caloric needs, weight management, and fitness optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic testing market also includes sales of metabolic analyzers, calorimeters, indirect calorimetry systems, and wearable metabolic tracking devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Metabolic Testing Market Report 2026?

The metabolic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.